Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07581379 · ClinicalTrials.gov registry record
Advancing Precision Lung Cancer Surveillance and Outcomes in Diverse Populations
A clinical trial, sponsored by University of Florida.
- Active
- Registry status
- 1,826
- Enrollment target
NCT07581379 is a clinical trial that is active but no longer recruiting, run by University of Florida. The registered enrollment target is 1,826 participants.
The verdict
NCT07581379 is active but no longer recruiting, sponsored by University of Florida.
- ACTIVE NOT RECRUITING
- Registry status
- 1,826 participants
- Enrollment target
Study Summary
This observational study evaluates the effectiveness of computed tomography (CT) imaging surveillance after curative-intent treatment for stage I-IIIA non-small cell lung cancer (NSCLC) in a diverse U.S. population. The main questions are: How do CT surveillance use and adherence vary by race, ethnicity, and socioeconomic status? Does semi-annual CT surveillance improve outcomes compared with annual surveillance? Adults ages 20-90 with stage I-IIIA NSCLC treated between 2012 and 2026 will be identified using OneFlorida+ electronic health records, tumor registry data, claims, and clinical notes. Patients will be followed for up to five years after curative-intent therapy to evaluate surveillance patterns, recurrence, second primary lung cancers, complications, and survival.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,826 participants |
| Start Date | 2012-01 |
| Est. Completion | 2026-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07581379
The ClinicalTrials.gov registry entry for NCT07581379 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 1,826 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT07581379 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07581379 about?
NCT07581379 is a clinical study titled "Advancing Precision Lung Cancer Surveillance and Outcomes in Diverse Populations". This observational study evaluates the effectiveness of computed tomography (CT) imaging surveillance after curative-intent treatment for stage I-IIIA non-small cell lung cancer (NSCLC) in a diverse U.S. population. The main questions are: How do CT surveillance use and adherence vary by race, eth...
What is the current status of trial NCT07581379?
This trial is currently active not recruiting. The enrollment target is 1,826 participants. The study started on 2012-01. Estimated completion is 2026-12.
Who is sponsoring clinical trial NCT07581379?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.